What if you'd held TBPH?
A $1,000 investment in Theravance Biopharma, Inc. (TBPH) at the month-end close of 2014-05 would be worth $794 at the close of 2026-09 — -20.6% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $4,970.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2014
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2014 | $1,000 | — |
| 2015 | $1,099 | +9.9% |
| 2016 | $2,137 | +94.5% |
| 2017 | $1,869 | -12.5% |
| 2018 | $1,715 | -8.2% |
| 2019 | $1,735 | +1.2% |
| 2020 | $1,191 | -31.4% |
| 2021 | $741 | -37.8% |
| 2022 | $752 | +1.5% |
| 2023 | $753 | +0.2% |
| 2024 | $631 | -16.3% |
| 2025 | $1,254 | +98.8% |
| 2026 | $1,145 | -8.7% |
Best and worst month-end to buy
The best single month-end close to have bought TBPH was 2021-09 ($7.40): $1,000 then is $2,308 today. The worst was 2017-04 ($40.33): $1,000 then is $424.
FAQ
What would $1,000 in TBPH be worth today?
A $1,000 investment in Theravance Biopharma, Inc. (TBPH) at the start of 2014 would be worth about $794 today, a total return of -20.6%. Dividends are reinvested in these figures.
What were the best and worst years for TBPH?
Theravance Biopharma, Inc. (TBPH)'s strongest calendar year since 2014 was 2025, a +98.8% return — $1,000 held through that year became about $1,988 by year-end. Its weakest year was 2021, at -37.8%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in TBPH have grown?
Investing $100 at the end of every month since 2014-05 would have grown to about $17,131 on $14,900 invested.
Did TBPH beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $4,970. TBPH trailed the S&P 500 by +84.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Theravance Biopharma, Inc. (TBPH) historical total-return data from 2014-05 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.